-
公开(公告)号:AR095036A1
公开(公告)日:2015-09-16
申请号:ARP140100734
申请日:2014-03-06
Applicant: KALYRA PHARMACEUTICALS INC
Inventor: KEVIN DUANE BUNKER
IPC: C07C211/38 , A61K31/13 , A61K31/16 , A61K31/221 , C07C233/06
Abstract: Compuestos analgésicos para el tratamiento del dolor o la fiebre que incluyen una parte de biciclopentano unida a una amina, combinaciones de los compuestos con fármacos opioides, y métodos para tratar el dolor o la fiebre a través de la administración de un compuesto que se describe en la presente. Reivindicación 1: Un compuesto de fórmula (1), o a una sal farmacéuticamente aceptable de éste, en la cual R¹ es H, -CH₃, -CF₃, o un alquilo C₂₋₅ sustituido o no sustituido; R² os H o -C(=Y)R⁴; R³ es H, F, D, hidroxi, NH₂, alcoxi C₁₋₁₀ un alquilo C₁₋₃₀ sustituido o no sustituido, un alquenilo C₂₋₃₀ sustituido o no sustituido, un alquinilo C₂₋₃₀ sustituido o no sustituido, un cicloalquilo C₃₋₃₀ sustituido o no sustituido, un cicloalquenilo C₃₋₃₀ sustituido o no sustituido, un cicloalquinilo C₈₋₃₀ sustituido o no sustituido, un arilo C₆₋₃₀ sustituido o no sustituido, un heteroarilo sustituido o no sustituido, un heterociclilo sustituido o no sustituido, un aril(alquilo C₁₋₆) sustituido o no sustituido, un hetero(arilalquilo C₁₋₆) sustituido o no sustituido, un amido con enlace -N-sustituido o no sustituido, -(C=O)L o -O(C=O)R⁵, donde -(C=O)L es un grupo de salida de éster profármaco hidrolizable; R⁴ es CF₃ o un alquilo C₁₋₁₀ sustituido o no sustituido; R⁵ es alquilo C₁₋₆ sustituido o no sustituido o un aril(alquilo C₁₋₆) sustituido o no sustituido; e Y es S u O; con la condición de que cuando R³ es hidrógeno, R¹ y R² no pueden ser hidrógeno ambos. Reivindicación 36: El compuesto de acuerdo con la reivindicación 1, caracterizado porque el compuesto se selecciona entre el grupo que comprende el grupo de formulas (2).
-
公开(公告)号:WO2018067512A8
公开(公告)日:2018-04-12
申请号:PCT/US2017/054865
申请日:2017-10-03
Applicant: KALYRA PHARMACEUTICALS, INC.
Inventor: HUANG, Peter, Qinhua , KAHRAMAN, Mehmet , BUNKER, Kevin, Duane
IPC: C07D487/10 , A61K31/33 , A61P35/00
Abstract: Disclosed herein are spirocyclic compounds, together with pharmaceutical compositions and methods of ameliorating and/or treating a cancer described herein with one or more of the compounds described herein.
-
公开(公告)号:WO2017205459A1
公开(公告)日:2017-11-30
申请号:PCT/US2017/034163
申请日:2017-05-24
Applicant: KALYRA PHARMACEUTICALS, INC.
Inventor: BUNKER, Kevin, Duane , HUANG, Peter, Qinhua , ABRAHAM, Sunny , PINCHMAN, Joseph, Robert , HOPKINS, Chad, Daniel , SLEE, Deborah, Helen
IPC: C07D403/14 , C07D209/04 , A61K31/404 , A61P35/00
Abstract: Disclosed herein are nitrogen-containing bicyclic compounds, together with pharmaceutical compositions and methods of ameliorating and/or treating a cancer described herein with one or more of the compounds described herein.
Abstract translation: 本文公开了含氮双环化合物以及药物组合物以及用本文所述的一种或多种化合物改善和/或治疗本文所述癌症的方法。 p> p> p> p>
-
公开(公告)号:WO2017160922A1
公开(公告)日:2017-09-21
申请号:PCT/US2017/022430
申请日:2017-03-15
Applicant: KALYRA PHARMACEUTICALS, INC.
Inventor: BUNKER, Kevin, Duane , SLEE, Deborah, Helen , HOPKINS, Chad, Daniel , PINCHMAN, Joseph, Robert , KAHRAMAN, Mehmet , HUANG, Peter, Qinhua
IPC: A61K31/136 , A61K31/137 , A61K31/165 , A61K31/167 , A61P25/06 , A61P29/00 , A61K31/421 , A61K31/426 , A61K31/4245 , A61K31/433 , A61K31/415 , A61K31/44 , A61K31/505 , C07D277/28 , C07D285/135 , C07D285/12 , C07D271/113 , C07D277/40 , C07D239/42 , C07D213/73 , C07D263/48 , C07D231/12 , C07D213/38 , C07D285/08 , C07D277/32 , C07C211/52 , C07C211/29 , C07C233/13 , C07C233/15 , C07C233/07 , C07C233/25
Abstract: Disclosed herein are compounds of Formula (I), methods of synthesizing compounds of Formula (I), and methods of using compounds of Formula (I) as an analgesic.
-
公开(公告)号:WO2014149819A1
公开(公告)日:2014-09-25
申请号:PCT/US2014/021038
申请日:2014-03-06
Applicant: KALYRA PHARMACEUTICALS, INC.
Inventor: BUNKER, Kevin, Duane
IPC: C07C233/23 , C07C233/52 , C07C233/06 , C07C233/41 , C07C211/38 , A61K31/16 , A61K31/221 , A61K31/235 , A61K31/13
CPC classification number: A61K31/16 , A61K9/0014 , A61K9/0019 , A61K31/13 , A61K31/133 , A61K31/14 , A61K31/215 , A61K31/216 , A61K31/22 , A61K31/221 , A61K31/235 , A61K31/24 , A61K45/06 , C07C211/62 , C07C217/52 , C07C233/06 , C07C233/23 , C07C233/41 , C07C233/52 , C07C233/63 , C07C235/74 , C07C2602/38
Abstract: Analgesic compounds for treatment of pain or fever that include a bicyclopentane moiety linked to an amine, combinations of the compounds with opioid analgesic drugs, and methods for treating pain or fever by administering a compound described herein.
Abstract translation: 用于治疗疼痛或发热的止痛化合物,其包括与胺连接的双环戊烷部分,化合物与阿片类止痛药的组合,以及通过施用本文所述的化合物治疗疼痛或发热的方法。
-
公开(公告)号:WO2018106571A1
公开(公告)日:2018-06-14
申请号:PCT/US2017/064435
申请日:2017-12-04
Applicant: KALYRA PHARMACEUTICALS, INC.
Inventor: BUNKER, Kevin, Duane , PINCHMAN, Joseph, Robert
IPC: C07H17/08 , A61K31/7048 , A61P31/10
Abstract: Compounds of the Formulae (I) and (II) as described herein, or pharmaceutically acceptable salts thereof, are described, along with pharmaceutical compositions comprising such compounds, salts or combinations thereof, as well as methods for using them to make compounds of the Formula (Illa) and/or (Illb), and/or other compounds of the Formulae (I) and (II). Such compounds, salts and compositions are useful for inhibiting fungal growth. For example, in an embodiment, fungal infections can be treated by administering effective amounts of such compounds, salts and/or compositions to a subject in need thereof.
-
公开(公告)号:WO2018067512A1
公开(公告)日:2018-04-12
申请号:PCT/US2017/054865
申请日:2017-10-03
Applicant: KALYRA PHARMACEUTICALS, INC.
Inventor: HUANG, Peter, Qinhua , KAHRAMAN, Mehmet , BUNKER, Kevin, Duane
IPC: C07D487/10 , A61K31/33 , A61P35/00
Abstract: Disclosed herein are spirocyclic compounds, together with pharmaceutical compositions and methods of ameliorating and/or treating a cancer described herein with one or more of the compounds described herein.
Abstract translation: 本文公开了螺环化合物以及药物组合物以及用本文所述的一种或多种化合物改善和/或治疗本文所述癌症的方法。 p> p> p> p>
-
公开(公告)号:WO2017160925A1
公开(公告)日:2017-09-21
申请号:PCT/US2017/022433
申请日:2017-03-15
Applicant: KALYRA PHARMACEUTICALS, INC.
Inventor: BUNKER, Kevin, Duane , SLEE, Deborah, Helen , HOPKINS, Chad, Daniel , PINCHMAN, Joseph, Robert , KAHRAMAN, Mehmet , HUANG, Peter, Qinhua
IPC: A61K31/13 , A61K31/16 , A61K31/33 , A61P25/06 , A61P29/00 , A61K31/337 , A61K31/397 , A61K31/335 , A61K31/341 , A61K31/40 , A61K31/4468 , A61K31/351 , C07D205/04 , C07D205/12 , C07D207/14 , C07D211/58 , C07D305/14 , C07D307/22 , C07D309/14 , C07D313/04 , C07D487/10
CPC classification number: A61K31/397 , A61K9/0019 , A61K9/0053 , A61K31/135 , A61K31/137 , A61K31/337 , A61K31/34 , A61K31/341 , A61K31/35 , A61K31/351 , A61K31/40 , A61K31/439 , A61K31/445 , A61K31/4465 , A61K31/4468 , A61K31/4535 , A61K31/454 , A61K31/485 , A61K31/55 , A61K45/06 , A61P29/00 , A61K2300/00
Abstract: Disclosed herein are compounds of Formulae (I), and (II), methods of synthesizing compounds of Formulae (I) and (II), and methods of using compounds of Formulae (I) and (II) as an analgesic.
Abstract translation: (I)和(II)的化合物,合成式(I)和(II)化合物的方法以及使用式(I)和(II)化合物的方法 )作为镇痛剂。 p>
-
公开(公告)号:WO2017100171A1
公开(公告)日:2017-06-15
申请号:PCT/US2016/065097
申请日:2016-12-06
Applicant: KALYRA PHARMACEUTICALS, INC.
Inventor: PINCHMAN, Joseph Robert , BUNKER, Kevin Duane , HUANG, Peter Qinhua , SLEE, Deborah Helen , HOPKINS, Chad Daniel , KAHRAMAN, Mehmet
IPC: C07H17/08 , A61K31/7048 , A61P31/10
Abstract: Compounds of the Formula (I) and (II) as described herein, or pharmaceutically acceptable salts thereof, are described, along with pharmaceutical compositions comprising such compounds, salts or combinations thereof, and methods for making them. Such compounds, salts and compositions are useful for inhibiting fungal growth. For example, in an embodiment, fungal infections can be treated by administering effective amounts of such compounds, salts and/or compositions to a subject in need thereof.
Abstract translation: 描述了如本文所述的式(I)和(II)的化合物或其药学上可接受的盐,以及包含此类化合物,其盐或其组合的药物组合物及其制备方法 。 这样的化合物,盐和组合物可用于抑制真菌生长。 例如,在一个实施方案中,真菌感染可以通过向有需要的受试者施用有效量的此类化合物,盐和/或组合物来治疗。 p>
-
公开(公告)号:IL285318B
公开(公告)日:2022-09-01
申请号:IL28531821
申请日:2021-08-02
Applicant: KALYRA PHARMACEUTICALS INC , RECURIUM IP HOLDINGS LLC
IPC: A61K31/437 , A61K31/438 , A61P35/00 , C07B59/00 , C07C69/732 , C07C69/738 , C07C69/757
Abstract: Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.
-
-
-
-
-
-
-
-
-